×
Veru EBIT 2010-2024 | VERU
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Veru ebit from 2010 to 2024. Ebit can be defined as earnings before interest and taxes.
View More
Veru EBIT 2010-2024 | VERU
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Veru ebit from 2010 to 2024. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$231B
Boston Scientific (BSX)
$155.5B
Stryker (SYK)
$147.4B
EssilorLuxottica (ESLOY)
$140.8B
Medtronic (MDT)
$112.8B
Lonza Group Ag (LZAGY)
$47.1B
Haleon (HLN)
$44.8B
GE HealthCare Technologies (GEHC)
$42.1B
Agilent Technologies (A)
$39B
ResMed (RMD)
$34.2B
Terumo (TRUMY)
$26.3B
Koninklijke Philips (PHG)
$23.5B
Zimmer Biomet Holdings (ZBH)
$20.6B
Insulet (PODD)
$20.2B
Baxter (BAX)
$17.1B
Sunny Optical Technology (SNPTF)
$11.3B
Smith & Nephew SNATS (SNN)
$11.2B
BellRing Brands (BRBR)
$9.5B
Bio-Rad Laboratories (BIO)
$8B
Demant (WILYY)
$7.9B
Lantheus Holdings (LNTH)
$5.6B
Prestige Consumer Healthcare (PBH)
$4.2B
ICU Medical (ICUI)
$4B
Envista Holdings (NVST)
$3.7B
Perrigo (PRGO)
$3.4B
Haemonetics (HAE)
$3.2B
Shandong Weigao Medical Polymer (SHWGF)
$3B
GN Store Nord (GNNDY)
$2.9B
QuidelOrtho (QDEL)
$2.8B
LeMaitre Vascular (LMAT)
$2.3B